Comparison of the number of patients needed to treat with abciximab, eptifibatide and tirofiban to prevent death or myocardial infarction

被引：0
|
作者：
Wilson, MG
Jamal, HH
Wischet, W
Reid, P
机构：
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3552
引用
收藏
页码：650 / 650
页数：1
相关论文
共 50 条
  • [31] Randomized Comparison of Eptifibatide Versus Abciximab in Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction Results of the EVA-AMI Trial
    Zeymer, Uwe
    Margenet, Alain
    Haude, Michael
    Bode, Christoph
    Lablanche, Jean-Marc
    Heuer, Hubertus
    Schroeder, Rolf
    Kropff, Stefan
    Bourkaib, Ryad
    Banik, Norbert
    Zahn, Ralf
    Teiger, Emmanuel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (06) : 463 - 469
  • [32] Investigating platelet activation with abciximab and high-dose tirofiban in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
    van Werkum, JA
    Gerritsen, WM
    Kelder, HC
    Haas, FJLM
    Suttorp, MJ
    Bai, ET
    Rensing, BJWM
    Ernst, SMPG
    ten Berg, JM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 99A - 99A
  • [33] Effects of single high-dose bolus of tirofiban or abciximab during primary angioplasty for acute myocardial infarction in patients with renal failure
    Colangelo, S.
    Boccuzzi, G.
    Garbo, R.
    Noussan, P.
    Campo, G.
    Valgimigli, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 205 - 205
  • [34] Drugs to Prevent Bronchopulmonary Dysplasia: Effect of Baseline Risk on the Number Needed to Treat
    Jensen, Erik A.
    Roberts, Robin S.
    Schmidt, Barbara
    JOURNAL OF PEDIATRICS, 2020, 222 : 244 - 247
  • [35] Comparison of abciximab with "high-dose" tirofiban in patients undergoing percutaneous coronary intervention
    Gunasekara, AP
    Walters, DL
    Aroney, CN
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 109 (01) : 16 - 20
  • [36] Comparison of Abciximab Versus Eptifibatide During Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction (from the HORIZONS-AMI Trial)
    Singh, Harsimran S.
    Dangas, George D.
    Guagliumi, Giulio
    Yu, Jennifer
    Witzenbichler, Bernhard
    Kornowski, Ran
    Grines, Cindy
    Gersh, Bernard
    Dudek, Darius
    Mehran, Roxana
    Stone, Gregg W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07) : 940 - 947
  • [37] Numbers needed to treat with posaconazole prophylaxis to prevent invasive fungal infection and death
    Cornely, Oliver A.
    Ullmann, Andrew J.
    CLINICAL INFECTIOUS DISEASES, 2008, 46 (10) : 1626 - 1627
  • [38] Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
    Stone, GW
    Grines, CL
    Cox, DA
    Garcia, E
    Tcheng, JE
    Griffin, JJ
    Guagliumi, G
    Stuckey, T
    Turco, M
    Carroll, JD
    Rutherford, BD
    Lansky, AJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 957 - 966
  • [39] Using eptifibatide in patients undergoing coronary angioplasty with acute myocardial infarction
    Wong, CB
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 60 (03) : 423 - 424
  • [40] Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction
    Zaki, Tarek M.
    Gamal, Adel
    El Hamady, Walid A.
    Mansour, Sherief
    Abu Arab, Tamer M.
    EGYPTIAN HEART JOURNAL, 2011, 63 (02) : 109 - 115
12345